
Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them - 2
Understanding Various Sorts of Financial balances: An Extensive Outline - 3
Jesse Jackson hospitalized, under observation for a neurodegenerative condition - 4
Man threatens attack on German high-speed train, injures several - 5
Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
I traveled to 13 countries in 2025. This small island nation surprised me the most.
Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims
Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
Kids may be more likely to get the new ‘Cicada’ variant of Covid-19, scientists say. Here’s what to know about BA.3.2
Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George'
CDC's upcoming vote on hepatitis B vaccine could impact childhood immunization
Burkina Faso forces killed twice as many civilians as jihadists, rights group says
The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
The Golden Globes gift bag has nearly $1 million worth of swag for some winners and presenters. What's in it?












